Clinical and correlative results of SWOG S0354: A phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

Tanya B. Dorff, Bryan Goldman, Jacek K. Pinski, Philip Mack, Primo N Lara, Peter J. Van Veldhuizen, David I. Quinn, Nicholas J. Vogelzang, Ian M. Thompson, Maha H A Hussain

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and correlative results of SWOG S0354: A phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences